Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer
Some studies have revealed that specific genetic mutations could be associated with chemotherapy response or even survival in small-cell lung cancer (SCLC). Our retrospective study aimed to identify the correlation between genetic mutations and progression-free survival (PFS) in extensive-stage SCLC...
Main Authors: | Dongfang Chen, Jianlin Xu, Rong Qiao, Yizhuo Zhao, Tianqing Chu, Baohui Han, Runbo Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2020/8811487 |
Similar Items
-
Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer
by: Lian Yu, et al.
Published: (2021-08-01) -
The Clinical Analysis of First-Line Palitaxel Plus Platinum-Based Chemotherapy to Treat Elderly Non-Small Cell Lung Cancer
by: Tianqing CHU, et al.
Published: (2009-04-01) -
Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases
by: Rong Qiao, et al.
Published: (2019-03-01) -
Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer
by: Tianqing CHU, et al.
Published: (2009-11-01) -
Does surgically resected small‐cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
by: Yuqing Lou, et al.
Published: (2020-05-01)